Science News - July 31, 2026
New laboratory model could speed treatment development for rare, deadly melanomas
Researchers at the University of Turku have developed a new preclinical model that could help accelerate drug development for BAP1-deficient melanomas, a rare and highly aggressive form of melanoma that is resistant to current immunotherapies.
Europe - July 13, 2026
At the forefront of stem cell research
Spanish biochemist and molecular biologist Salvador Aznar Benitah’s research focuses on how adult stem cells function in normal conditions, aging, and cancer, with particular interest in epigenetics, circadian rhythms, and the mechanisms that allow certain cancer cells to initiate metastasis.
Science News - July 8, 2026
Antibodies in the nose may protect against influenza infection
High levels of influenza-specific IgA antibodies in the nasal mucosa are linked to a reduced risk of infection, according to a new study from Danderyd Hospital and SciLifeLab.
Science article - July 8, 2026
Screening by smelling
Electronic noses open up possibilities for developing non-invasive approaches for early disease detection.
Funding - June 3, 2026
Charlotte Thålin awarded SEK 20 million grant for COPD research
Thålin has been awarded the Swedish Heart-Lung Foundation’s major research grant for her work on antibody-based protection against infections in chronic obstructive pulmonary disease (COPD).
Science article - June 3, 2026
Nasal organoids: Bridging the gap between lab and clinic
Growing two or three-dimensional human nasal tissue can lead to better reliability in research studies, personalized treatment strategies, and ultimately contribute to better outcomes for patients.






